# Budesonide for Mycophenolic Acid-induced Diarrhea in Renal Transplant Recipients

> **NCT02991768** · PHASE2 · TERMINATED · sponsor: **University of Kansas Medical Center** · enrollment: 9 (actual)

## Conditions studied

- Diarrhea

## Interventions

- **DRUG:** Entocort
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT02991768
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01-27
- **Primary completion:** 2019-04-26
- **Final completion:** 2019-04-26
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Enrollment not continued
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02991768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02991768, "Budesonide for Mycophenolic Acid-induced Diarrhea in Renal Transplant Recipients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02991768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*